Cyproterone acetate in the treatment of oestrogen hypersensitivity vulvovaginitis

  title={Cyproterone acetate in the treatment of oestrogen hypersensitivity vulvovaginitis},
  author={Yvonne Nguyen and Jennifer Bradford and Gayle Fischer},
  journal={Australasian Journal of Dermatology},
Oestrogen hypersensitivity vulvovaginitis is a rare chronic cyclical vulvovaginitis responsive to oestrogen suppression or antagonism. We present a case series of 16 patients with refractory cyclical vulvovaginitis, all of whom responded to oestrogen suppression with cyproterone acetate. 


A chronic and extensive distinctive pruritic vesiculobullous eruption in a young woman resembled dermatitis herpetiformis clinically and erythema multiforme histologically and revealed that flares could be excited by progesterone and progestational compounds.
Vulvitis attributed to hypersensitivity to estrogen. A report of 11 cases.
This is the first report of vulvitis due to estrogen hypersensitivity reported, and specific therapy aimed at suppressing or antagonizing estrogen may be required in patients with unexplained cyclic Vulvitis unresponsive to standard therapy or in those developing noncandidal vulVitis on HRT.
Treatment of endometriosis with cyproterone acetate. Preliminary report.
The possible therapeutic use of cyproterone acetate in endometriosis is disclosed, with positive results for dysmenorrhea and menstrual disorders in seven patients.
Autoimmune progesterone dermatitis: Update and insights.
The wide spectrum of clinical presentations, histology, and response to therapy would suggest that there are multiple subsets in APD, and further research on the pathogenesis of APD is required to provide a satisfactory treatment modality.
Estrogen dermatitis.
Seven women exhibiting severe premenstrual exacerbations of papulovesicular eruptions, urticaria, eczema, or generalized pruritus proved to have an unrecognized sensitivity to estrogen, which is named estrogen dermatitis.
[Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Endometrial carcinoma and hyperplasia risk increased during a much longer exposure to tamoxifen and in combination with such factors as obesity, diabetes mellitus, uterine myoma and estrogen-type colpocytological response.
Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
  • M. Dutertre, C. Smith
  • Biology, Medicine
    The Journal of pharmacology and experimental therapeutics
  • 2000
This model provides a basis for understanding the molecular mechanisms of SERM action, and should help identify new SERMs with enhanced tissue or target gene selectivity.
Estrogen receptors in human nontarget tissues: biological and clinical implications.
The study of ER has been improved with the advent and widespread use of monoclonal antibodies against the receptor protein and the presence ofER has been described in numerous normal and pathological tissues using ligandbinding and immunochemical assays.
Estrogen Regulates Vaginal Sensory and Autonomic Nerve Density in the Rat1
Findings indicate that some aspects of vaginal dysfunction during menopause may be attributable to changes in innervation, and sympathetic innervation may augment vasoconstriction and promote vaginal dryness, while sensory nociceptor axon proliferation may contribute to symptoms of pain, burning, and itching associated withMenopause and some forms of vulvodynia.